Rigel Pharmaceuticals | Crediti Commerciali





Crediti Commerciali Cambiamento Data
Agenus USD 354K 53K 2025-03
Amgen USD 9.57B 1.08B 2025-12
Anika Therapeutics USD 21.99M 1.61M 2025-03
Arrowhead Research USD 218.87M 212.05M 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
BioMarin Pharmaceutical USD 790.27M 65.59M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Celldex Therapeutics USD 90K 0 2025-09
Daiichi Sankyo JPY 695.95B 79.1B 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Halozyme Therapeutics USD 346.04M 29.7M 2025-09
Heron Therapeutics USD 67.04M 6.9M 2024-09
Intrexon USD 1.02M 559K 2024-06
Ionis Pharmaceuticals USD 24.61M 27.97M 2025-09
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
MacroGenics USD 69.23M 56.7M 2025-09
Neurocrine Biosciences USD 728M 132.3M 2025-09
Pfizer USD 18.12B 2.02B 2025-09
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Veracyte USD 47.83M 2.99M 2025-09


Rigel Pharmaceuticals Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.